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Chronic total occlusion (CTO) percutaneous coro-nary intervention (PCI) of in-stent occlusions can be challenging. If crossing through the stent struts 
fails, an alternative crossing strategy is to cross beneath the 
stent struts, followed by implantation of new stents, “crush-
ing” the formerly placed stents. We describe such a case of 
“sub-stent” CTO crossing using the retrograde approach 
that was complicated by fracture of the shaft of the bal-
loon used for postdilation (Figures 1A-1L). A similar subin-
timal crossing and crush technique of an in-stent restenotic 
lesion in the distal coronary artery has been reported by 
others, with continued patency documented on coronary 
angiography performed 9 months later. While the long-term 
outcomes of subintimal stenting require further study, early 
results appear promising. 
Balloon shaft fracture can potentially have serious conse-
quences, such as embolization, urgent surgery, or even death. 
If the balloon fragment is at least partially within the guide 
catheter, retrieval is usually done by inflating another bal-
loon inside the guide catheter, “trapping” the fractured shaft 
segment between the balloon and the guide catheter inner 
wall, followed by withdrawal of the entire system. However, 
this maneuver was not possible in our case, as the exter-
nalized wire was within the antegrade catheter; hence, the 
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FIGURE 1. (A, B) A 74-year-old man presented with Canadian Cardiovascular Society (CCS) class IV angina with several co-
morbidities and was referred for PCI of a right coronary artery (RCA) CTO. (B) Seven years prior, he underwent RCA-PCI to 
treat ST-segment elevation acute myocardial infarction. Five years prior, he presented with non-ST segment elevation acute 
myocardial infarction and was found to have an occluded RCA stent that could not be recanalized. (C) Given the presence of a 
well-defined proximal cap and a good re-entry zone, antegrade dissection re-entry with the CrossBoss microcatheter (Boston 
Scientific) and a Pilot 200 guidewire (Abbott Vascular) was selected as the initial crossing strategy. The wire was switched to 
a Gaia Second wire, but because of the lack of support (ostial lesion, AL1 guide) the CrossBoss catheter could not be advanced 
past the proximal cap. The CrossBoss catheter was changed for a Corsair microcatheter (Asahi Intecc), but antegrade cross-
ing failed despite using multiple guidewires (Confianza Pro 12, Hornet 14, Pilot 200, Gaia Second). Retrograde crossing was 
attempted. A septal collateral was easily crossed with a Sion guidewire using the “surfing” technique. The Corsair catheter did 
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FIGURE 1. (continued) (D) The distal end of the stent could not be crossed despite using multiple guidewires (Pilot 200, Gaia Second, 
Hornet 14, Confianza Pro 12, Miracle 12). (E) A knuckle was formed using a Pilot 200 guidewire and was advanced in the sub-stent space. 
(F) Antegrade crossing was very challenging, but sub-stent crossing was achieved using a Hornet 14 guidewire. (G) Antegrade advance-
ment of several balloons (2.5 x 12 mm, 1.2 x 12 mm) failed, but a Threader 1.2 x 12 mm microcatheter (Boston Scientific) crossed the prox-
imal cap. Using the reverse controlled antegrade and retrograde tracking and dissection technique, the retrograde guidewire entered 
the antegrade guide catheter. Following advancement of the Corsair microcatheter, an RG3 wire (Asahi Intecc) was externalized. After 
predilation with 2 x 15 mm and 3 x 20 mm balloons, a 3 x 38 mm drug-eluting stent (DES) was deployed distally and 3.5 x 38 mm DES, 
proximally “crushing” the old stent. (H, I) Based on the angiography after stent deployment, a 3.0 x 20 mm balloon was inserted for 
postdilation, but the shaft of the balloon broke, leaving an approximately 60 cm-long segment of the balloon catheter inside the guide 
catheter on the externalized guidewire. After failed attempts to snare the entrapped balloon catheter fragment, a decision was made 
to retract the antegrade guide catheter, which enabled retrieval of the fractured balloon shaft. (J) The ostium of the RCA was stented 
with a 3.5 x 12 mm DES and postdilated with 3.0 x 20 mm and 3.5 x 20 mm non-compliant balloons. (K) Final angiography revealed TIMI 
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antegrade catheter could not be withdrawn with a balloon 
inflated within its shaft. After measuring the balloon frag-
ment length, it became apparent that it was long enough to 
be retrieved by withdrawing the antegrade guide catheter 
(without inflating a balloon inside its shaft), as was success-
fully done. In summary, subintimal crossing and crushing of 
an occluded previously deployed stent can allow successful 
crossing of in-stent CTOs when other strategies fail. Bal-
loon shaft fracture can be challenging to treat in the setting 
of retrograde CTO-PCI with guidewire externalization; 
withdrawal of the guide catheter without simultateous bal-
loon inflation within its shaft may allow successful removal 
of the balloon shaft fragment if the latter is long enough.
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